Tuesday, March 31, 2020

The $20 Solution to Coronavirus: 'Anecdotal Evidence' Is a Life-Saver

Following clinical trials in China, South Korea, and France that demonstrated the efficacy of treating and likely preventing COVID-19 infections with HCQ alone or in combination with azithromycin, President Trump expressed to the media optimism about HCQ being a potential "Game changer" in the fight to defeat the pandemic.

In answer to a reporter's question, Fauci stated that although there was "Anecdotal evidence" that HCQ was effective in treating and preventing COVID-19 infections, controlled clinical trials of the drug were still necessary before any definite conclusions could be reached.

In a follow-up of its previously reported study recommending the use of HCQ and azithromycin to treat COVID-19 cases, researchers in France and Vietnam under the leadership of world-renowned infectious disease expert Professor Didier Raoult, the head of the Institut Hospitalo-Universitaire Méditerranée Infection in Marseille, have reported another clinical trial in which that drug combination cured 79 out of 80 patients.

According to the Bahrain News Agency, the head of Bahrain's National Taskforce for Combatting COVID-19 reports that HCQ has had a "Profound impact" when used to treat COVID-19 patients.

Belgium has established a "Strategic reserve" of HCQ to treat as many as 22,000 COVID-19 patients on an "Off-label" basis.

The anecdotal evidence demonstrates that the majority of high risk COVID-19 patients can be saved by early dosing with HCQ and without tying up hospital and ICU beds or the use of ventilators.

In the meantime, ask yourselves if there is any good reason why we should delay for one second a nationwide crash program to ramp up production of HCQ and deploy Dr. Zelenko's $20 solution and similar effective protocols to defeat the COVID-19 pandemic.


No comments: